Mercer Global Advisors
ARNA

Mercer Global Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Mercer Global Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,774
Closed -$243K – 1208
2020
Q1 		$243K Buy
+5,774
New +$265K 0.01% 884

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mercer Global Advisors's ARNA Position: Q2 2020 in Review

Mercer Global Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2020, closing a stake of 5,774 shares — an estimated $243K sold.

Mercer Global Advisors first reported a position in ARNA in Q1 2020 and held it in 1 quarter. The position peaked at $243K in Q1 2020. 247 funds tracked by Wall St. Rank hold ARNA as of Q2 2020.

  • Mercer Global Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Mercer Global Advisors sold 5,774 Arena Pharmaceuticals Inc shares in Q2 2020, an estimated $243K.
  • Mercer Global Advisors first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and held it in 1 quarter.
  • Mercer Global Advisors's Arena Pharmaceuticals Inc position peaked at $243K in Q1 2020.
  • 247 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2020.

Based on Mercer Global Advisors's 13F filing for Q2 2020, filed 10 Aug 2020.